Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest update to the EASL Clinical Practice Guidelines on the use of non-invasive tests for the evaluation of liver disease severity and prognosis, focusing on the topics for which relevant evidence has been published in the last 5 years
Funding Information: The work was supported by the National Research Programme in Medicine 2006–2009...
The diagnostic assessment of liver fibrosis is an important step in the management of patients with ...
We report the evidence-based Italian Association for the Study of Liver guidelines for the appropria...
Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chron...
The Clinical Practice Guidelines propose recommendations for the diagnosis, treatment and follow-up ...
The Clinical Practice Guidelines (CPG) propose recommendations for the diagnosis, treatment and foll...
The Clinical Practice Guidelines propose recommendations for the diagnosis, treatment and follow-up ...
Non-alcoholic fatty liver disease (NAFLD) is very common in people with type 2 diabetes and although...
Non-alcoholic fatty liver disease is a new epidemic liver disease, thus, its early diagnosis and the...
Alcoholic liver disease (ALD) is the most prevalent cause of advanced liver disease in Europe. Howev...
Non-alcoholic fatty liver disease is a new epidemic liver disease, thus, its early diagnosis and the...
Purpose of review: To improve understanding of recent developments in the noninvasive assessment of ...
Over the last two decades, there have been tremendous advances in the non-invasive diagnosis and ris...
Aim: In this systematic review, guidelines on non-alcoholic fatty liver disease (NAFLD) were evaluat...
Funding Information: The work was supported by the National Research Programme in Medicine 2006–2009...
The diagnostic assessment of liver fibrosis is an important step in the management of patients with ...
We report the evidence-based Italian Association for the Study of Liver guidelines for the appropria...
Non-invasive tests are increasingly being used to improve the diagnosis and prognostication of chron...
The Clinical Practice Guidelines propose recommendations for the diagnosis, treatment and follow-up ...
The Clinical Practice Guidelines (CPG) propose recommendations for the diagnosis, treatment and foll...
The Clinical Practice Guidelines propose recommendations for the diagnosis, treatment and follow-up ...
Non-alcoholic fatty liver disease (NAFLD) is very common in people with type 2 diabetes and although...
Non-alcoholic fatty liver disease is a new epidemic liver disease, thus, its early diagnosis and the...
Alcoholic liver disease (ALD) is the most prevalent cause of advanced liver disease in Europe. Howev...
Non-alcoholic fatty liver disease is a new epidemic liver disease, thus, its early diagnosis and the...
Purpose of review: To improve understanding of recent developments in the noninvasive assessment of ...
Over the last two decades, there have been tremendous advances in the non-invasive diagnosis and ris...
Aim: In this systematic review, guidelines on non-alcoholic fatty liver disease (NAFLD) were evaluat...
Funding Information: The work was supported by the National Research Programme in Medicine 2006–2009...
The diagnostic assessment of liver fibrosis is an important step in the management of patients with ...
We report the evidence-based Italian Association for the Study of Liver guidelines for the appropria...